Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 May;122(5):1600-2.
doi: 10.1172/JCI63066. Epub 2012 Apr 23.

Gene therapy: too much splice can spoil the dish

Affiliations
Comment

Gene therapy: too much splice can spoil the dish

Didier Trono. J Clin Invest. 2012 May.

Abstract

The use of integrating vectors for gene therapy - required for stable correction of gene expression - carries the risk of insertional mutagenesis, which can lead to activation of a tumorigenic program. In this issue of the JCI, Moiani et al. and Cesana et al. investigate how viral vectors can induce aberrant splicing, resulting in chimeric cellular-viral transcripts. The finding that this is a general phenomenon is concerning, but some of their results do suggest approaches for the development of safeguards in gene therapy vector design.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Vector-induced chimeric transcripts.
(A) A cellular gene producing an mRNA endowed with a regulatory miRNA target sequence at its 3′ end. Protein product is described at right. (B) The same gene, with a vector provirus integrated between two exons in the sense orientation. Two general categories of aberrant mRNAs are depicted as either 5′ (av) or 3′ (va/vb) fusions between vector (v) and cellular transcripts. Compared with its physiological counterpart (a), av mRNA yields a truncated cellular protein (potentially fused to a fragment of the transgenic protein) at high levels, owing to the loss of 3′ miRNA target sequences. va results from proviral transcriptional read-through, and vb results from the use of a cryptic splice donor in the vector. Only the transgenic protein is produced at significant levels from va, as translation of the cellular part of this transcript would require reinitiation, a very inefficient process. The resulting transcript is predicted to be expressed at low levels, irrespective of the presence of an miRNA target sequence, due to nonsense-mediated degradation. (C) The provirus-harboring locus, with insertion of target sequences for a stage-specific miRNA in the vector transcript as a safeguard. Both vector-derived (v*) and cellular-viral fusion (av*, v*a) mRNAs will be degraded in cells expressing the miRNA, e.g., transformation-prone stem cells, resulting in very low levels of abnormal protein. However, a vb-like mRNA devoid of miRNA target sequence owing to aberrant splicing would escape downregulation, as would av-like transcripts generated from a provirus integrated in the antisense orientation.

Comment on

References

    1. Hacein-Bey-Abina S, et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. . N Engl J Med. 2010;363(4):355–364. doi: 10.1056/NEJMoa1000164. - DOI - PMC - PubMed
    1. Cavazzana-Calvo M, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288(5466):669–672. doi: 10.1126/science.288.5466.669. - DOI - PubMed
    1. Cavazzana-Calvo M, et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature. 2010;467(7313):318–322. doi: 10.1038/nature09328. - DOI - PMC - PubMed
    1. Aiuti A, et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med. 2009;360(5):447–458. doi: 10.1056/NEJMoa0805817. - DOI - PubMed
    1. Cartier N, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science. 2009;326(5954):818–823. doi: 10.1126/science.1171242. - DOI - PubMed

Publication types

Substances

LinkOut - more resources